Department of Gastroenterological Surgery, Kagawa University, Kagawa, Japan.
Department of Surgery, Kindai University, Osaka, Japan.
Surgery. 2022 Sep;172(3):962-967. doi: 10.1016/j.surg.2022.04.031. Epub 2022 Jul 9.
The number of total pancreatectomy cases have increased worldwide, expanding the need for new insulin products and high-titer pancrelipases. However, the current data that is focused on hypoglycemic events after a total pancreatectomy from large nationwide series are still lacking. This study is aimed to assess the risk factors associated with hypoglycemic events after a total pancreatectomy.
Data were prospectively collected from 216 consecutive patients who underwent total pancreatectomies between August 2015 and December 2017 from 68 Japanese centers. Of the 216 patients, 166 with a follow-up period of 1 year were analyzed. The risk factors for hypoglycemic events at 6 and 12 months (postoperative months 6 and 12) were investigated based on the results of a nationwide multicenter prospective study.
Of the 166 patients, 57 (34%) and 70 (42%) experienced moderate or severe hypoglycemic events or hypoglycemia unawareness on a monthly basis at postoperative months 6 and 12, respectively. Multivariate analysis revealed that body weight loss after surgery ≥0.3 kg and total cholesterol level ≤136 mg/dL at postoperative month 6, and glycated hemoglobin level ≤8.9% and rapid-acting insulin use at postoperative month 12 were independent risk factors for hypoglycemic events after a total pancreatectomy. There were different independent risk factors depending on the postoperative period.
Patients with body weight loss after surgery, low total cholesterol level, strict glycemic control, and using rapid-acting insulin should be aware of the occurrence of hypoglycemic events after their total pancreatectomy. In order to prevent hypoglycemic events after a total pancreatectomy, we need to consider optimal nutritional and glycemic control according to the postoperative period.
全世界范围内全胰切除术的病例数量有所增加,这使得对新的胰岛素产品和高浓度胰酶制剂的需求也有所增加。然而,目前仍缺乏来自大型全国性系列研究的关于全胰切除术后低血糖事件的相关数据。本研究旨在评估与全胰切除术后低血糖事件相关的危险因素。
数据是从 2015 年 8 月至 2017 年 12 月间,68 家日本中心的 216 名连续全胰切除术患者前瞻性收集而来。在这 216 名患者中,对 166 名具有 1 年随访期的患者进行了分析。根据全国多中心前瞻性研究的结果,对术后 6 个月(术后第 6 个月)和 12 个月(术后第 12 个月)时发生低血糖事件的危险因素进行了调查。
在这 166 名患者中,分别有 57 名(34%)和 70 名(42%)在术后第 6 个月和第 12 个月每月发生中度或重度低血糖事件或无症状性低血糖。多变量分析显示,术后体重减轻≥0.3kg 和术后第 6 个月总胆固醇水平≤136mg/dL,以及术后第 12 个月糖化血红蛋白水平≤8.9%和使用速效胰岛素是全胰切除术后发生低血糖事件的独立危险因素。不同的独立危险因素取决于术后时期。
对于术后体重减轻、总胆固醇水平低、严格血糖控制和使用速效胰岛素的患者,应注意全胰切除术后低血糖事件的发生。为了预防全胰切除术后低血糖事件,我们需要根据术后时期考虑最佳的营养和血糖控制。